DiaMedica Therapeutics Reaches Oversold Levels (DMAC)

Avatar photo

Warren Buffett’s investment strategy emphasizes being cautious when others are greedy and opportunistic when others are fearful. This is illustrated by the Relative Strength Index (RSI), a technical analysis tool measuring momentum between 0 and 100; stocks with an RSI below 30 are considered oversold.

On Wednesday, shares of DiaMedica Therapeutics Inc (Symbol: DMAC) recorded an RSI of 28.4, indicating oversold conditions after trading as low as $6.065 each. In contrast, the S&P 500 ETF (SPY) has an RSI of 57.1. DMAC’s 52-week trading range spans a low of $3.26 to a high of $10.4195, with the last trade at $6.19.

The free Daily Market Overview 250k traders and investors are reading

Read Now